COVID-19 continues to claim lives around the world and is infecting millions more. Although several vaccines have recently become available, making significant strides towards preventing COVID-19, what about the treatment of those who already have the infection? Vaccines aren’t 100% effective, highlighting the need—now more than ever—for effective antiviral therapeutics. Moreover, some people can’t receive vaccines due to health issues, and new variants of SARS-CoV-2, the virus that causes COVID-19, that can penetrate vaccine-conferred immunity, are being reported, indicating that we need to think beyond prevention.
To achieve this goal, the researchers first established an experimental system for screening drugs that may help to control infections. This system used a type of cells called VeroE6/TMPRSS2 cells, which were manipulated to efficiently be infected with and produce SARS-CoV-2. “To determine whether a drug of interest could help combat infection by SARS-CoV-2, we simply had to expose VeroE6/TMPRSS2 cells to both the drug and SARS-CoV-2 and then observe whether the drug’s presence served to hinder the virus’s efforts to infect cells,” explains Professor Watashi.
The researchers used this experimental system to screen a panel of drugs that are already approved for clinical use, including drugs like remdesivir and chloroquine that have already being approved or are being trialed as treatments for COVID-19. In an exciting outcome, the researchers found two drugs that provided effective SARS-CoV-2 suppression: cepharanthine, which is used to treat inflammation, and nelfinavir, which is approved for the treatment of HIV infection.
Cepharanthine inhibited the entry of the virus into cells by preventing the virus from binding to a protein on the cell membrane, which it uses as a gateway. In contrast, nelfinavir worked to prevent the virus from replicating inside the cell by inhibiting a protein that the virus relies on for replication. Given that these drugs have distinct antiviral mechanisms, using both of them together could be especially effective for patients, with computational models predicting that combined cepharanthine/nelfinavir therapy can hasten the clearance of SARS-CoV-2 from a patient’s lungs by as few as 4.9 days.
The rare lung disease is so complicated that its acronym is difficult to pronounce. However, for infants who were unfortunate enough to be born with this disorder, the outcome is generally fatal. Left: normal [...]
Researchers analyzed data on three variants of concern and found that viral loads were higher and infection lasted longer for the B.1.1.7 variant. They all were more infectious than the original strain, and transmissibility [...]
A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer/BioNTech and Moderna, according to data from two vaccine safety monitoring systems, the U.S. [...]
Probably you’ve heard about hacking smartphones, emails, cards, computers. Even hacking elections. But what about hacking your body? What?! This concept is called biohacking and it’s really all about self-improvement. The possibilities are endless, all around [...]
Over the course of the coronavirus pandemic, various conspiracy theories surrounding the COVID-19 vaccine have arisen, with one of the most popular pieces of false information being that the shots contain microchips. Now, scientists [...]
COVID-19 continues to claim lives around the world and is infecting millions more. Although several vaccines have recently become available, making significant strides towards preventing COVID-19, what about the treatment of those who already [...]
People who have received the Pfizer vaccine have lower antibody levels that target the Delta variant, first discovered in India, than those that targeted previously circulating variants in the UK, new data suggests. The study found that [...]
Medical researchers with the Chinese army engineered mice with humanized lungs in 2019 to test viruses on them, it has been reported. The mice, developed using CRISPR gene-editing technology, were mentioned in an April 2020 study which researched [...]
Healthcare systems across Africa are “far from ready” to cope with a fresh surge of coronavirus infections, with vaccine deliveries at a near standstill and cases surging in many countries, the World Health Organization [...]
All viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus’ properties. However, some changes may affect the virus’s properties, such as how easily it spreads, the associated disease severity, or [...]
Vaccines can be great at preventing you from getting sick, while at the same time not necessarily stopping you from getting infected or spreading the germ. Preliminary evidence seems to suggest the COVID-19 vaccines [...]
People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Many people who have been infected with [...]
British spies believe that the thesis that COVID-19 leaked from a lab in China is plausible and are seeking to recruit sources on the darknet as they investigate the claim, reported The Sunday Times. Sources [...]
A team of German scientists believe that they have worked out why some people given the AstraZeneca and Johnson & Johnson vaccines against Covid-19 develop blood clots – and claim they can tell the manufacturers how to improve [...]
The United States is closer than ever to beating Covid-19, with half the country vaccinated and more restrictions lifting. But we're as far as ever from knowing how this virus, which shut down the world, [...]